Skip to main content
Fig. 4 | Journal of Hematology & Oncology

Fig. 4

From: Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial

Fig. 4

Comparisons in survival between patients with and without RCCEP. a Kaplan-Meier curve of PFS. b Kaplan-Meier curve of OS. All 217 patients treated with camrelizumab were included in the analysis. RCCEP, reactive cutaneous capillary endothelial proliferation; PFS, progression-free survival; OS, overall survival

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us